Reconstituted High Density Lipoprotein, a Versatile Drug Delivery Nanoplatform for Tumor Therapy

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-B-066-Tuesday
• By: WANG, Wei (China Pharmaceutical University, Pharmaceutics, Nanjing, China)
• Co-author(s): Wei Wang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  Fangrong Zhang: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  Jianping Zhou: Pharmaceutics, China Pharmaceutical University, Nanjing, China
  
• Abstract:

  Backgrounds

  Reconstituted high density lipoprotein (rHDL) represents an excellent biomimetic tool for targeted delivery of chemical/biological agents (chemotherapeutics, DNA, siRNAs, photosensitizers, etc.) into various tumor cells. These rHDL nanoparticles offer many advantages for antitumor drug delivery over their native counterparts while..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login